K. Culos

发表

American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Survey on Chimeric Antigen Receptor T Cell Therapy Administrative, Logistic, and Toxicity Management Practices in the United States.

Dragos Plesca, Zahra Mahmoudjafari, Katie S. Gatwood, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative.

M. DeBaun, T. Koyama, A. Kassim, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide

Heidi Chen, A. Kassim, M. Jagasia, 2020, EJHaem.

Foiling fungal disease post hematopoietic cell transplant: review of prophylactic strategies

S. Rubinstein, B. Savani, K. Culos, 2018, Bone Marrow Transplantation.

Immunosuppressive agents and monitoring in long‐term survivors

Katie S. Gatwood, K. Culos, 2021, Blood and Marrow Transplantation Long Term Management.

Preparative regimen dosing for hematopoietic stem cell transplantation in patients with chronic hepatic impairment: analysis of the literature and recommendations.

B. Savani, K. Culos, M. Bodge, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program.

Heidi Chen, A. Kassim, B. Savani, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Maintenance Strategies After Hematopoietic Cell Transplantation

M. Byrne, Katie S. Gatwood, K. Culos, 2020, Pharmacotherapy.

Novel Targets in the Treatment of Advanced Melanoma: New First-Line Treatment Options

S. Cuéllar, K. Culos, 2013, The Annals of pharmacotherapy.

Risk factors associated with early viral reactivation following haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: a pilot study

A. Kassim, B. Savani, M. Jagasia, 2020, Annals of Hematology.

Efficacy and Pharmacoeconomic Impact of Letermovir for CMV Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients

A. Kassim, B. Savani, M. Jagasia, 2019, Biology of Blood and Marrow Transplantation.

Ivosidenib: IDH1 Inhibitor for the Treatment of Acute Myeloid Leukemia

K. Culos, Houston Wyatt, Shelby Merchant, 2019, Journal of the advanced practitioner in oncology.

Alternative Agents to Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections

J. Cannon, S. Grim, K. Culos, 2013, American journal of therapeutics.

Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia

A. Kassim, J. Greer, B. Savani, 2018, Bone Marrow Transplantation.

Incidence and Severity of Oral Mucositis after High-Dose Melphalan in Stem Cell Transplant Patients: A Pilot Study of Oral Cryotherapy

K. Culos, Kanz, B. Savani, 2016 .

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC2)

Michael J. Eckrich, M. DeBaun, T. Koyama, 2020, Blood.

Katie S. Gatwood, Angela A Hsieh, K. Culos, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.